Mortality in Children with Classic Congenital Adrenal Hyperplasia and 21-Hydroxylase Deficiency (CAH) in Germany (original) (raw)
Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency
Fred C. G. J. Sweep
Journal of pediatric endocrinology & metabolism : JPEM, 2017
View PDFchevron_right
Classical Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Croatia Between 1995 and 2012
Veselin Skrabic
2013
View PDFchevron_right
Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Croatia between 1995 and 2006
Gordana Stipancic
Hormone Research, 2009
View PDFchevron_right
Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2010
Ingeborg Barisic
2011
View PDFchevron_right
Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia
Oliver Blankenstein
The Journal of Clinical Endocrinology & Metabolism, 2020
View PDFchevron_right
Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study
Irina Bacila
European Journal of Endocrinology
View PDFchevron_right
Benefits of Neonatal Screening for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in Sweden
A. Nordenström
Pediatrics, 1998
View PDFchevron_right
Increased Mortality in Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Henrik Falhammar
The Journal of Clinical Endocrinology & Metabolism, 2014
View PDFchevron_right
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A five-year retrospective study in the Children's Hospital of Damascus, Syria
asad alebrahem
Qatar medical journal, 2015
View PDFchevron_right
CLINICAL PROFILE OF PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA DUE TO 21 HYDROXYLASE DEFIICIENCY
National Journal of Medical Research, Dr. Asif Ahmed
National Journal of Medical Research, 2016
View PDFchevron_right
Long-Term Outcome of Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
Mohamed Abid
The American Journal of the Medical Sciences, 2012
View PDFchevron_right
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Henrik Falhammar
International Journal of Neonatal Screening
View PDFchevron_right
Primary Adrenal Insufficiency in Childhood: Data From a Large Nationwide Cohort
Mariella Valenzise
The Journal of Clinical Endocrinology & Metabolism, 2020
View PDFchevron_right
Growth in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Helmuth Dörr
Hormone Research in Paediatrics, 2007
View PDFchevron_right
Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Carlos Seas
Indian Journal of Endocrinology and Metabolism, 2012
View PDFchevron_right
Metabolic evaluation of young women with congenital adrenal hyperplasia
Lilia Li
Arquivos Brasileiros de Endocrinologia & Metabologia, 2011
View PDFchevron_right
Growth in infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: An analysis of the factors affecting height
Amina Salam
Egyptian Pediatric Association Gazette, 2013
View PDFchevron_right
[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form]
Maria Tereza Baptista
Arquivos brasileiros de endocrinologia e metabologia, 2005
View PDFchevron_right
Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
Liat Devries
Endocrine, 2021
View PDFchevron_right
An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
William Reiner
International Journal of Pediatric Endocrinology, 2010
View PDFchevron_right
Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Helmuth Dörr
Pediatrics, 2006
View PDFchevron_right
Blood Pressure in Children with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Irina Bacila
Hormone Research in Paediatrics
View PDFchevron_right
One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study
Ulrika Von Döbeln, Henrik Falhammar
View PDFchevron_right
Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Karl Schwab
Molecular and Cellular Pediatrics, 2020
View PDFchevron_right
Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: A meta-analysis
Roopa Seshadri, Erica Eugster
The Journal of Pediatrics, 2001
View PDFchevron_right
CONGENITAL ADRENAL HYPERPLASIA DUE TO IMPAIRED 21-HYDROXYLASE AFFECTS GROWTH AND DEVELOPMENT
Mary Coleen Diango
View PDFchevron_right
Metabolic Profile and Body Composition in Adult Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Agneta Nordenskjöld
The Journal of Clinical Endocrinology & Metabolism, 2007
View PDFchevron_right
Trends in diagnostics and treatment of congenital adrenal hyperplasia
Vladimir Kojovic
Medicinska istrazivanja
View PDFchevron_right
Congenital adrenal hyperplasia: an update in children
Phyllis Speiser
Current Opinion in Endocrinology, Diabetes and Obesity, 2011
View PDFchevron_right
Treatment of congenital adrenal hyperplasia in children aged 0–3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure
Oliver Blankenstein
European Journal of Endocrinology, 2022
View PDFchevron_right